Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Anti-Müllerian hormone (AMH) is currently used as an ovarian reserve marker for individualized fertility counseling, but very little is known of individual AMH decline in women. This study assessed whether the decline trajectory of AMH is uniform for all women, and whether baseline age-specific AMH levels remain consistently high or low during this trajectory. METHODS: A total of 3326 female participants from the population-based Doetinchem Cohort Study were followed with five visits over a 20-year period. Baseline age was 40 ± 10 years with a range of 20-59 years. AMH was measured in 12,929 stored plasma samples using the picoAMH assay (AnshLabs). Decline trajectories of AMH were studied with both chronological age and reproductive age, i.e., time to menopause. Multivariable linear mixed effects models characterized the individual AMH decline trajectories. RESULTS: The overall rate of AMH decline accelerated after 40 years of age. Mixed models with varying age-specific AMH levels and decline rates provided the significantly best fit to the data, indicating that the fall in AMH levels over time does not follow a fixed pattern for individual women. AMH levels remained consistent along individual trajectories of age, with an intraclass correlation coefficient (ICC) of 0.87. The ICC of 0.32 for AMH trajectories with time to menopause expressed the large variation in AMH levels at a given time before the menopause. The differences between low and high age-specific AMH levels remained distinguishable, but became increasingly smaller with increasing chronological and reproductive age. CONCLUSIONS: This is the first study to characterize individual AMH decline over a long time period and broad age range. The varying AMH decline rates do not support the premise of a uniform AMH decline trajectory. Although age-specific AMH levels remain consistently high or low with increasing age, the converging trajectories and variance of AMH levels at a given time before menopause shed doubt on the added value of AMH to represent individualized reproductive age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ovarian aging: mechanisms and clinical consequences
Broekmans, F. J., Soules, M. R., & Fauser, B. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0006 · Cited by 1,248 · cited 2×
“Anti-Müllerian hormone (AMH), produced by follicular granulosa cells, has recently emerged as a promising biomarker representing the number of remaining follicles in the ovaries [1].”
BackgroundSelf-citationThe variability of female reproductive ageing
te Velde, E. R. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.2.141 · Cited by 1,214
Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro
Carlsson, I. B. (2006) · Human Reproduction · doi:10.1093/humrep/del165 · Cited by 294 · cited 1×
“This could potentially mean that the suggested inhibitory effect of AMH on follicle recruitment [28 – 30] is effective up to a certain age or ovarian reserve threshold.”
Cited by
Anti-müllerian hormone and ovarian reserve: Update on assessing ovarian function
Moolhuijsen, L. M. E., & Visser, J. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa513 · Cited by 584
“Furthermore, it was shown that the decline rate changed with age, accelerating after the age of 40 years (58).”
BackgroundSelf-citationCurrent Guidelines for Diagnosing PCOS
Christ, J. P., & Cedars, M. I. (2023) · Diagnostics · doi:10.3390/diagnostics13061113 · Cited by 340
Prediction of age at menopause in women with polycystic ovary syndrome
Minooee, S., Ramezani Tehrani, F., Rahmati, M., Mansournia, M. A., & Azizi, F. (2018) · Climacteric · doi:10.1080/13697137.2017.1392501 · Cited by 55
Vallée, A., Feki, A., Poulain, M., & Ayoubi, J.-M. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.108977 · Cited by 1
Metadata
- Authors
- de Kat, A. C., van der Schouw, Y. T., Eijkemans, M. J. C., Herber-Gast, G. C., Visser, J. A., Verschuren, W. M. M., & Broekmans, F. J. M.
- Venue
- BMC Medicine
- Published
- 2016-10-03
- Volume
- 14
- Issue
- 1
- Pages
- 151-151
- ISSN
- 1741-7015 (ISSN-L)
- OpenAlex
- W2524561829
- Cited by
- 126
- References
- 3
- FWCI
- 10.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline. https://app.cochat.ai/papers/10.1186/s12916-016-0699-y
- The paper
- de Kat, A. C., van der Schouw, Y. T., Eijkemans, M. J. C., Herber-Gast, G. C., Visser, J. A., Verschuren, W. M. M., & Broekmans, F. J. M. (2016). Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline. BMC Medicine. https://doi.org/10.1186/s12916-016-0699-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.